Profile
Kelly O’Brien Wilson currently works at Forte Animal Health, Inc., as Director from 2020 and Biostax Corp., as Chief Operating Officer from 2022.
Ms. Wilson also formerly worked at Biostax Corp., as CTO & Director-Human Resources from 2015 to 2020, Biostax Corp., as Chief Executive & Operating Officer in 2023, and Cytocom, Inc., as Chief Technology & Information Officer from 2016 to 2020.
Ms. Wilson received her undergraduate degree and graduate degree from the University of Central Florida.
Kelly Wilson active positions
| Companies | Position | Start |
|---|---|---|
| BIOSTAXPAR | Chief Operating Officer | 01/08/2022 |
Forte Animal Health, Inc. | Director/Board Member | 01/12/2020 |
Former positions of Kelly Wilson
| Companies | Position | End |
|---|---|---|
| BIOSTAXPAR | Chief Executive Officer | 25/07/2023 |
| BIOSTAXPAR | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Chief Tech/Sci/R&D Officer | 01/04/2020 |
Training of Kelly Wilson
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 4 |
|---|---|
University of Central Florida
University of Central Florida Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Biostax Corp.
Biostax Corp. Pharmaceuticals: MajorHealth Technology Manufactures and develops pharmaceutical & biotechnology products | Health Technology |
Cytocom, Inc. /Old/
Cytocom, Inc. /Old/ BiotechnologyHealth Technology Operates as clinical-stage biopharmaceutical company, which develops novel small molecule immunotherapies | Health Technology |
Forte Animal Health, Inc. | Process Industries |
- Stock Market
- Insiders
- Kelly Wilson
















